Cite
101P The coexistence of TP53 gain-of-function mutation and hypermethylation as a poor prognostic factor in BRAF wild-type metastatic colorectal cancer.
MLA
Ouchi, K., et al. “101P The Coexistence of TP53 Gain-of-Function Mutation and Hypermethylation as a Poor Prognostic Factor in BRAF Wild-Type Metastatic Colorectal Cancer.” Annals of Oncology, vol. 34, Nov. 2023, p. S1510. EBSCOhost, https://doi.org/10.1016/j.annonc.2023.10.236.
APA
Ouchi, K., Wakayama, S., Takahashi, S., Yamada, Y., Komatsu, Y., Shimada, K., Yamaguchi, T., Shirota, H., Takahashi, M., & Ishioka, C. (2023). 101P The coexistence of TP53 gain-of-function mutation and hypermethylation as a poor prognostic factor in BRAF wild-type metastatic colorectal cancer. Annals of Oncology, 34, S1510. https://doi.org/10.1016/j.annonc.2023.10.236
Chicago
Ouchi, K., S. Wakayama, S. Takahashi, Y. Yamada, Y. Komatsu, K. Shimada, T. Yamaguchi, H. Shirota, M. Takahashi, and C. Ishioka. 2023. “101P The Coexistence of TP53 Gain-of-Function Mutation and Hypermethylation as a Poor Prognostic Factor in BRAF Wild-Type Metastatic Colorectal Cancer.” Annals of Oncology 34 (November): S1510. doi:10.1016/j.annonc.2023.10.236.